Alternative Growth Behavior of Mycobacterium Avium Subspecies and Staphylococci with Implications for Clinical Microbiology and Blood Culture

Rapid culture of Mycobacterium avium subspecies paratuberculosis (MAP) from patients remains a challenge. During the process of developing a rapid culture method for MAP, we found that there is an alternative growth behavior present in MAP, MAH (Mycobacterium avium subspecies hominissuis) and other bacteria such as Staphylococcus aureus, and Staphylococcus pseudintermedius. The bacterial DNA, RNA and proteins are present in the supernatants of the liquid culture media after routine microcentrifugation. When cultured in the solid media plate, there are a limited number of colonies developed for MAP and MAH disproportionate to the growth. We believe there is an alternative growth behavior for MAP, MAH and other bacteria similar to “phenoptosis”. Based on the alternative bacterial growth behavior, we tested 62 blood culture specimens that have been reported negative by routine automated blood culture method after 5 days of incubation. We used alternative culture media and molecular diagnostic techniques to test these negative culture bottles, and we found a large percentage of bacterial growth by alternative culture media (32%) and by molecular PCR amplification using 16s rDNA primer set and DNA sequencing (69%). The sensitivity of detection by the molecular PCR/sequencing method is significantly higher than by routine automated blood culture. Given the challenge of early diagnosis of sepsis in the hospital setting, it is necessary to develop more sensitive and faster diagnostic tools to guide clinical practice and improve the outcome of sepsis management.

[1]  J. T. Kuenstner,et al.  Mycobacterium avium subspecies hominissuis in Crohn’s disease: a case report , 2015, Gastroenterology report.

[2]  G. Rogler,et al.  Gut Bacterial DNA Translocation is an Independent Risk Factor of Flare at Short Term in Patients With Crohn’s Disease , 2016, The American Journal of Gastroenterology.

[3]  L. Sechi,et al.  Type 1 Diabetes at-risk children highly recognize Mycobacterium avium subspecies paratuberculosis epitopes homologous to human Znt8 and Proinsulin , 2016, Scientific Reports.

[4]  L. Sechi,et al.  Recognition of ZnT8, Proinsulin, and Homologous MAP Peptides in Sardinian Children at Risk of T1D Precedes Detection of Classical Islet Antibodies , 2015, Journal of diabetes research.

[5]  L. Sechi,et al.  Epitopes of HERV-Wenv induce antigen-specific humoral immunity in multiple sclerosis patients , 2015, Journal of Neuroimmunology.

[6]  Xiang Y Han,et al.  Subspecies Identification and Significance of 257 Clinical Strains of Mycobacterium avium , 2014, Journal of Clinical Microbiology.

[7]  T. Nikai,et al.  Comparative Genome Analysis of Mycobacterium avium Revealed Genetic Diversity in Strains that Cause Pulmonary and Disseminated Disease , 2013, PloS one.

[8]  A. Kuna Serological markers of inflammatory bowel disease , 2013, Biochemia medica.

[9]  M. Behr,et al.  Paratuberculosis: organism, disease, control , 2010 .

[10]  R. Jover,et al.  Cytokine association with bacterial DNA in serum of patients with inflammatory bowel disease , 2009, Inflammatory bowel diseases.

[11]  T. Ezaki,et al.  Translocation of Salmonella typhimurium in rats on total parenteral nutrition correlates with changes in intestinal morphology and mucus gel. , 2004, Nutrition.

[12]  J. Lyczak,et al.  Salmonella enterica Serovar Typhi Modulates Cell Surface Expression of Its Receptor, the Cystic Fibrosis Transmembrane Conductance Regulator, on the Intestinal Epithelium , 2002, Infection and Immunity.

[13]  V. Skulachev Phenoptosis: programmed death of an organism. , 1999, Biochemistry. Biokhimiia.

[14]  M. Evans,et al.  Salmonella typhi uses CFTR to enter intestinal epithelial cells , 1998, Nature.

[15]  L. Bermudez,et al.  Phage infection, transfection and transformation of Mycobacterium avium complex and Mycobacterium paratuberculosis. , 1995, Microbiology.

[16]  R. Chiodini,et al.  Spheroplastic phase of mycobacteria isolated from patients with Crohn's disease , 1986, Journal of clinical microbiology.

[17]  R. Chiodini,et al.  In vitro antimicrobial susceptibility of a Mycobacterium sp. isolated from patients with Crohn's disease , 1984, Antimicrobial Agents and Chemotherapy.

[18]  R. Chiodini,et al.  Characteristics of an unclassified Mycobacterium species isolated from patients with Crohn's disease , 1984, Journal of clinical microbiology.

[19]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[20]  S. Udaka,et al.  Protein Excretion through Bleb Formation by PE4LA, a Mutant of Escherichia coli , 1980 .

[21]  S. Udaka,et al.  Isolation and Characterization of Protein-leaky Mutants of Escherichia coli , 1978 .